...PHARMACEUTICAL SOCIAL EQUITY Trademark

Trademark Overview

On Friday, June 27, 2003, a trademark application was filed for ...PHARMACEUTICAL SOCIAL EQUITY with the United States Patent and Trademark Office. The USPTO has given the ...PHARMACEUTICAL SOCIAL EQUITY trademark a serial number of 78267991. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 24, 2006. This trademark is owned by Aspreva Pharmaceutical Corporation. The ...PHARMACEUTICAL SOCIAL EQUITY trademark is filed in the Advertising, Business and Retail Services category with the following description:

Development and commercialization of pharmaceutical drugs for less common diseases

General Information

Serial Number78267991
Word Mark...PHARMACEUTICAL SOCIAL EQUITY
Filing DateFriday, June 27, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 24, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDevelopment and commercialization of pharmaceutical drugs for less common diseases
Pseudo MarkPHARMACEUTICAL SOCIAL EQUITY

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 9, 2003
Primary Code035
First Use Anywhere DateThursday, March 27, 2003
First Use In Commerce DateThursday, March 27, 2003

Trademark Owner History

Party NameAspreva Pharmaceutical Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVictoria V8Z 7X8
CA

Trademark Events

Event DateEvent Description
Monday, July 24, 2006ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, July 24, 2006ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 28, 2005NON-FINAL ACTION MAILED
Sunday, November 27, 2005NON-FINAL ACTION WRITTEN
Thursday, November 10, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, November 2, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 2, 2005PETITION TO REVIVE-GRANTED
Wednesday, November 2, 2005TEAS PETITION TO REVIVE RECEIVED
Wednesday, November 2, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 30, 2005ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, September 30, 2005ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 24, 2005NON-FINAL ACTION E-MAILED
Thursday, February 24, 2005NON-FINAL ACTION WRITTEN
Monday, February 14, 2005PETITION TO REVIVE-GRANTED
Monday, September 13, 2004PETITION TO REVIVE-RECEIVED
Monday, September 13, 2004PETITION TO REVIVE-RECEIVED
Monday, September 13, 2004PAPER RECEIVED
Friday, August 13, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 24, 2003NON-FINAL ACTION E-MAILED
Friday, November 21, 2003ASSIGNED TO EXAMINER

Related Keywords

equity social pharmaceutical common diseases less drugs commercialization development